BRIEF-Advanced Biomed Announces Pricing Of Initial Public Offering-March 2024-www.financetom.com

BRIEF-Advanced Biomed Announces Pricing Of Initial Public Offering

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Advanced Biomed Announces Pricing Of Initial Public Offering

Mar 6, 2025 6:33 AM

March 6 (Reuters) - Advanced Biomed Inc:

* ADVANCED BIOMED INC. ANNOUNCES PRICING OF INITIAL PUBLIC

OFFERING

* ADVANCED BIOMED: PRICING OF IPO OF 1.6 MILLION SHARES AT

$4.00

PER SHARE

Source text:

Further company coverage:

([email protected])

Previous page： Natera Rolls Out New Policy for Commercial Coverage of Fetal RhD Noninvasive Prenatal Test in US Next page： --Simpson Manufacturing Keeps Quarterly Dividend at $0.28 a Share, Payable April 24 to Holders of Record April 3

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Natera Rolls Out New Policy for Commercial Coverage of Fetal RhD Noninvasive Prenatal Test in US

Feb 3, 2025

11:07 AM EST, 02/03/2025 (MT Newswires) -- Natera ( NTRA ) on Monday announced a new policy for commercial coverage of its cell-free DNA fetal RhD noninvasive prenatal test in the US. Under the new policy, coverage of fetal RhD testing will be available when a pregnancy may be facing risk for alloimmunization, when paternal antigen typing is unavailable or...

--Simpson Manufacturing Keeps Quarterly Dividend at $0.28 a Share, Payable April 24 to Holders of Record April 3

Feb 3, 2025

11:11 AM EST, 02/03/2025 (MT Newswires) -- Price: 166.93, Change: -1.07, Percent Change: -0.64 ...

Jupiter Neurosciences Signs Manufacturing Deal With Catalent Pharma for Jotrol Softgel Capsules

Feb 3, 2025

11:10 AM EST, 02/03/2025 (MT Newswires) -- Jupiter Neurosciences ( JUNS ) said Monday that it signed an agreement with Catalent Pharma Solutions for the production of Jotrol softgel capsules for Jupiter's upcoming phase 2a clinical trial in Parkinson's disease. Jotrol is Jupiter's oral formulation of resveratrol and under the deal, Catalent will manufacture clinical batches of Jotrol using a...

JBS to pay $83.5 million in latest beef price-fixing settlement

Feb 3, 2025

Feb 3 (Reuters) - JBS has agreed to pay $83.5 million to settle antitrust claims that it conspired with other meat-packing companies to curb supply in the U.S. beef market to artificially inflate prices. Ranchers and other plaintiffs disclosed their proposed settlement with the Brazilian company and its U.S. units on Friday in federal court in Minnesota. The settlement requires...